Pfizer BioNTech COVID-19 Vaccine

Share this story on:

“This vaccine is authorized for emergency use in persons age 16 years and older. This is a two-dose vaccine, given 21 days apart. Clinical trial data show the vaccine is 95% effective at preventing COVID-19 infection starting 7 days after the 2nd dose. Individual will not be considered fully protected until 2 weeks after the y receive the 2nd dose. The clinical trials revealed no major unanticipated adverse events. This vaccine arrived in Washington (state) on December 14th.”

-Washington State Department of Health

Teresa

Update: Full Vax Against COVID

Update: As of 4/30/21: Indiana= 1.76 million residents. 26.25% of state population. Kentucky= 1.40 million residents. 31.34% of state population. Florida= 6.13 million residents. 28.57%

Teresa April 30, 2021

Update/More Definitive Info Still Needed on COVID-19 Guidance

“A growing body of evidence suggests that fully vaccinated people are less likely to have asymptomatic infection and potentially less likely to transmit SARS-CoV-2 to

Teresa April 1, 2021

Here: Mask Required Through 5/31/21

Please Be Aware Masks will still be required in our office until May 31st at this time. Even though the Mask Mandate in Indiana has

Teresa March 31, 2021

Indiana Update

Over 954,000 people in the state of Indiana have been fully vaccinated against COVID-19. There are 548 people in Indiana hospitals because of COVID-19; and

Teresa March 22, 2021

Things to Know About 2021

Things to know about 2021: More of your earnings will be subject to Social Security taxation. Taxpayers will pay 6.2% Social Security tax and a

Teresa December 30, 2020

Unprecedented Collaboration

“… COVID 19 has led to unprecedented worldwide collaboration among scientists, medical doctors, health and government officials, and manufacturers…The arrival of this vaccine in Michigan

Teresa December 24, 2020